SCHEMBL6994408

SCHEMBL6994408

O=C(Nc1ccccc1)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.64
CHEK1 O14757 10/20 0.61
CDK1 P06493 1/20 0.57
CDK2 P24941 1/20 0.57
KIT P10721 1/20 0.52
FLT1 P17948 1/20 0.52
PDGFRB P09619 1/20 0.51
MAP4K1 Q92918 1/20 0.50
ROCK2 O75116 1/20 0.50
ROCK1 Q13464 1/20 0.50
PTPN1 P18031 2/20 0.49
NPC1 O15118 1/20 0.48
SGK1 O00141 1/20 0.47
AURKA O14965 1/20 0.47
CSNK2A2 P19784 1/20 0.47
AKT1 P31749 1/20 0.47
AKT2 P31751 1/20 0.47
CSNK2B P67870 1/20 0.47
CSNK2A1 P68400 1/20 0.47
AKT3 Q9Y243 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094928 0.95 KDR (0.64) KDRCHEK1CDK1CDK2KIT
Water SCHEMBL7089950 0.94 KDR (0.63) KDRCHEK1CDK1CDK2KIT
SCHEMBL7002081 0.92 CDK1 (0.67) KDRCHEK1CDK1CDK2KIT
SCHEMBL7696243 0.91 CHEK1 (0.57) KDRCHEK1CDK1CDK2KIT
SCHEMBL6999716 0.88 CHEK1 (0.53) KDRCHEK1CDK1CDK2KIT
SCHEMBL7703594 0.88 CHEK1 (0.53) KDRCHEK1CDK1CDK2KIT
SCHEMBL7705309 0.87 KDR (0.69) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7091231 0.86 CHEK1 (0.56) KDRCHEK1CDK1CDK2KIT
SCHEMBL6999537 0.86 CHEK1 (0.69) KDRCHEK1CDK1CDK2MAP4K1
SCHEMBL7002588 0.86 KDR (0.74) KDRCHEK1CDK1CDK2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed